January 5, 2026 · Form 4 insider transaction
Woody Joseph Fralin bought 29,446 shares of AVITA Medical, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 150 days after the transaction.
On January 5, 2026, the Board of Directors approved a grant of 29,446 options to acquire 29,446 shares of Common Stock of the Company to Mr. Woody as a new non-executive director, with an effective grant date of January 5, 2026 and an exercise price equal to the closing price of a share of Common Stock on Nasdaq on January 5, 2026 of $3.47. The grant was subject to the approval of the Company's stockholders, which was obtained on June 3, 2026.; These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date.